Peripheral blood cell mitochondrial dysfunction in myelodysplastic syndrome can be improved by a combination of coenzyme Q10 and carnitine

Kalman Filanovsky, Michal Haran, Vita Mirkin, Andrei Braester, Olga Shevetz, Anfisa Stanevsky, Erica Sigler, Ekaterina Votinov, Yehudit Zaltsman-Amir, Alain Berrebi, Atan Gross, Lev Shvidel

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Structural mitochondrial abnormalities and genetic aberrations in mitochondrial proteins have been known in Myelodysplastic syndrome (MDS), yet there is currently little data regarding MDS's metabolic properties and energy production cells. In the current study, we used state-of-the-art methods to assess OXPHOS in peripheral blood cells obtained from MDS patients and healthy controls. We then assessed the effect of food supplements- Coenzyme Q10 and carnitine on mitochondrial function and hematological response. We show here for the first time that there is a significant impairment of mitochondrial respiration in peripheral blood cells in low-risk MDS, which can be improved with food supplements. We also show that these supplements may improve the cytopenia and quality of life.

Original languageEnglish
Article numbere2020072
JournalMediterranean Journal of Hematology and Infectious Diseases
Volume12
Issue number1
DOIs
StatePublished - 1 Jan 2020
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2020 Universita Cattolica del Sacro Cuore. All rights reserved.

Keywords

  • Carnitine
  • Coenzyme Q10
  • Mitochondria
  • Myelodysplastic syndrome

Fingerprint

Dive into the research topics of 'Peripheral blood cell mitochondrial dysfunction in myelodysplastic syndrome can be improved by a combination of coenzyme Q10 and carnitine'. Together they form a unique fingerprint.

Cite this